Verrica Pharmaceuticals Inc.·4

Mar 3, 4:29 PM ET

White Ted 4

4 · Verrica Pharmaceuticals Inc. · Filed Mar 3, 2023

Insider Transaction Report

Form 4
Period: 2023-03-01
White Ted
DirectorPRESIDENT AND CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-03-01+240,000240,000 total
    Exercise: $7.58Exp: 2033-02-28Common Stock (240,000 underlying)
Footnotes (1)
  • [F1]25% of the total shares subject to the option shall vest on March 1, 2024 and 1/48th of the total shares subject to the option shall vest monthly thereafter over the remaining three years of the vesting period, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION